• About
CMM
Karolinska institutet
Karolinska universitetssjukhuset
Sök

Gene linked to rheumatic disease controls cell movement

A recent study from Marie Wahren-Herlenius’ Group at CMM reveals how the gene DIORA1, associated with several rheumatic diseases, affects how cells move. The findings provide new insights into disease mechanisms and potential future therapies. The study is published in the scientific journal PNAS and the first author is PhD student Tilen Tršelič.

Tilen Tršelič and Marie Wahren-Herlenius. Photos: Miranda Stiernborg and Rolf Adlercreutz, respectively.

Publication:Autoimmunity-associated DIORA1 binds the MRCK family of serine/threonine kinases and controls cell motility“, Tilen Tršelič, Nathalie Pelo, Gregoire Martin de Fremont, Vaishnavi S. Iyer, Elina Richardsdotter Andersson, Vijole Ottosson, David Alexander Frei, Elisa Baas, William A. Nyberg, Guðný Ella Thorlacius, Lara Mentlein, Sanjaykumar V. Boddul, Ioana Sandu, Diego Velasquez Pulgarin, Ákos Végvári, Carmen Gerlach, Fredrik Wermeling, Maria Sunnerhagen, Björn Wallner, Alexander Espinosa, Marie Wahren-Herlenius, PNAS, 29 September 2025, doi: 10.1073/pnas.2426917122

About CMM

The Center for Molecular Medicine (CMM) is a foundation instituted by the Stockholm County Council (Region Stockholm). CMM is at the heart of a close partnership with the Karolinska University Hospital and Karolinska Institutet, fueling advancements in biomedical and clinical research.

Contact

Center for Molecular Medicine Foundation, org. nr. 815201-3689

Karolinska University Hospital L8:05

Visionsgatan 18

171 76 Stockholm, Sweden

communication@cmm.se

CMM
Karolinska institutet
Karolinska universitetssjukhuset